Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol KTTA
- Company Pasithea Therapeutics Corp.
- Price $0.48
- Changes Percentage -5.85
- Change -0.0299
- Day Low $0.47
- Day High $0.52
- Year High $2.06
- Year Low $0.28
- Market Cap $17,165,001
- Price Avg 50 EMA (D) $0.5
- Price Avg 200 EMA (D) $0.72
- Exchange NASDAQ
- Volume 105,099
- Average Volume 685,647
- Open $0.52
- Previous Close $0.51
- EPS -1.6
- PE -0.32
- Earnings Announcement 2026-11-12 05:00:00
- Shares Outstanding $33,414,446
Company brief: PASITHEA THERAPEUTICS CORP. (KTTA )
- Healthcare
- Biotechnology
- Dr. Tiago Reis Marques M.D., Ph.D.
- https://www.pasithea.com
- US
- N/A
- 09-15-2021
- US70261F2020
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
